산부인과
백이선
진료분야 부인암 (난소암, 자궁경부암, 자궁내막암), 양성부인과 종양(자궁근종, 난소종양), da Vinci 로봇수술, 복강경수술, 자궁내시경 수술
진료예약모바일로 확인하실 경우 표를 좌우로 움직여 내용을 확인 하실 수 있습니다.
| 0000 00 |
|---|
| 오전 |
| 오후 |
진료과 사정에 따라 진료 일정이 변경될 수 있습니다. 자세한 일정은 진료과로 문의 바랍니다.
- 외래진료
- 국내 학회
- 국외 학회
- 강의
- 휴가
- 기타
| 0000 00 |
|---|
| 오전 |
| 오후 |
진료과 사정에 따라 진료 일정이 변경될 수 있습니다. 자세한 일정은 진료과로 문의 바랍니다.
- 외래진료
- 국내 학회
- 국외 학회
- 강의
- 휴가
- 기타
- 학회활동 더보기
-
- 대한산부인과학회 정회원
- 대한산부인과내시경학회 정회원
- 대한부인종양학회 정회원
- 대한부인종양연구회 정회원
- 2018~2019 대한부인종양학회 학술위원회 유전성부인암소위원회 위원
- 2018~2019 대한부인종양학회 기획위원회 부인암등록사업소위원회 간사
- 2020~2022 대한부인종양학회 편집위원회 소식지소위원회 간사
- 2021~2022 대한부인종양학회 부인암예방위원회 부인암진료권고안소위원회 (난소암) 위원
- 2021~2022 대한부인종양연구회 암예방분과위원회 간사
- 2021~2022 대한부인종양연구회 중개연구위윈회 간사
- 2021~2022 대한산부인과학회 편집위원회 위원
- 2021~2022 대한산부인과학회 수련제도발전 TFT 위원
- 2021~현재 대한부인종양연구회 희귀암분과위원회 위원
- 2022~현재 대한부인종양학회 편집위원회 소식지소위원회 위원
- 2022~현재 대한부인종양학회 윤리위원회 위원
- 2022~현재 대한부인종양연구회 중개연구위윈회 위원
- 수상경력 더보기
-
- 2021 제36차 대한부인종양학회 신풍호월학술상 JGO Best Paper Award
- 2020 제106차 대한산부인과학회 학술대회 Korean Society of Obstetrics and Gynecology 학술상 (부인종양학)
- 2017 제32차 대한부인종양학회 부인종양의학상 젊은의학자상
- 2017 제32차 대한부인종양학회 JGO (Journal of Gynecologic Oncology) Best Reviewer Award
- 2017 제103차 대한산부인과학회 학술대회 그레이스 특별학술기여상
- 2017 일본산부인과학회 (JSOG) Congress Encouragement Award
- 2017.03 대한부인종양학회 신풍호월학술상 최우수포스터상
- 2016 제102차 대한산부인과학회 학술대회 그레이스 우수논문상
- 2014 제100차 대한산부인과학회 학술대회 최우수포스터상
- 논문 더보기
-
- Changes in subcellular localization of Lysyl-tRNA synthetase and the 67-kDa laminin receptor in epithelial ovarian cancer metastases.Lee DH, Paik ES, Cho YJ, Lee YY, Lee B, Lee EJ, Choi JJ, Choi CH, Lee S, Choi JW, Lee JW. Cancer Biomark. 2022;35(1):99-109. doi: 10.3233/CBM-210077.
- Long-Term Outcomes of Reduced-Port Robotic Surgery (RPRS) for Uterine Myomectomy with the da Vinci Surgical System. Song JW, Lee GP, Kim WY, Paik ES. Clin. Exp. Obstet. Gynecol. 2022, 49(9), 200;https://doi.org/10.31083/j.ceog4909200
- Prognostic Relevance of BRCA1 Expression in Survival of Patients With Cervical Cancer. Paik ES, Chang CS, Chae YL, Oh SY, Byeon SJ, Kim CJ, Lee YY, Kim TJ, Lee JW, Kim BG, Choi CH. Front Oncol. 2021 Nov 8;11:770103. doi: 10.3389/fonc.2021.770103. eCollection 2021.
- Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer. Paik ES, Heo EJ, Choi CH, Kim JH, Kim JW, Kim YM, Park SY, Lee JW, Kim JW, Kim BG. Cancer Sci. 2021 Dec;112(12):5055-5067. doi: 10.1111/cas.15166. Epub 2021 Oct 25.
- Comparison of Laparoscopy and Laparotomy for Para-Aortic Lymphadenectomy in Women With Presumed Stage I-II High-Risk Endometrial Cancer. Paik ES, Baek SH, Kang JH, Jeong SY, Kim MS, Kim WY, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS, Kim TJ. Front Oncol. 2020 Apr 7;10:451. doi: 10.3389/fonc.2020.00451. eCollection 2020.
- Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer. Paik ES, Kim TH, Cho YJ, Ryu J, Choi JJ, Lee YY, Kim TJ, Choi CH, Kim WY, Sa JK, Lee JK, Kim BG, Bae DS, Han HD, Ahn HJ, Lee JW.
- Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study. Paik ES, Lee YJ, Lee JY, Shin W, Park SY, Kim SI, Kim JW, Choi CH, Kim BG. J Clin Med. 2019 Nov 8;8(11):1920. doi: 10.3390/jcm8111920.
- Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028).Paik ES, Lim MC, Kim MH, Kim YH, Song ES, Seong SJ, Suh DH, Lee JM, Lee C, Choi CH. Cancer Res Treat. 2020 Jan;52(1):320-333. doi: 10.4143/crt.2019.124. Epub 2019 Aug 5.
- Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028). Paik ES, Lim MC, Kim MH, Kim YH, Song ES, Seong SJ, Suh DH, Lee JM, Lee C, Choi CH. Gynecol Oncol. 2019 Sep;154(3):547-553. doi: 10.1016/j.ygyno.2019.06.023. Epub 2019 Jul 1.
- Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods. Paik ES, Lee JW, Park JY, Kim JH, Kim M, Kim TJ, Choi CH, Kim BG, Bae DS, Seo SW.J Gynecol Oncol. 2019 Jul;30(4):e65. doi: 10.3802/jgo.2019.30.e65. Epub 2019 Mar 11.
- Prognostic factors for recurrence and survival in uterine leiomyosarcoma: Korean single center experience with 50 cases. Paik ES, Kang JH, Kim J, Lee YJ, Choi CH, Kim TJ, Kim BG, Bae DS, Lee JW. Obstet Gynecol Sci. 2019 Mar;62(2):103-111. doi: 10.5468/ogs.2019.62.2.103. Epub 2019 Feb 12.
- Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis. Paik ES, Kim TJ, Choi CH, Kim BG, Bae DS, Lee JW. J Gynecol Oncol. 2018 Mar;29(2):e18. doi: 10.3802/jgo.2018.29.e18. Epub 2017 Dec 11.
- Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.Paik ES, Kim JH, Kim TJ, Lee JW, Kim BG, Bae DS, Choi CH. J Gynecol Oncol. 2018 Jan;29(1):e13. doi: 10.3802/jgo.2018.29.e13.
- Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer. Paik ES, Choi HJ, Kim TJ, Lee JW, Kim BG, Bae DS, Choi CH. Cancer Res Treat. 2018 Apr;50(2):461-473. doi: 10.4143/crt.2017.104. Epub 2017 May 22.
- Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer. Paik ES, Shim M, Choi HJ, Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS. Cancer Biomark. 2016;17(4):419-425. doi: 10.3233/CBM-160658.
- Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis.Paik ES, Shim M, Choi HJ, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS, Choi CH. Gynecol Oncol. 2016 Nov;143(2):252-257. doi: 10.1016/Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer. Paik ES, Sohn I, Baek SY, Shim M, Choi HJ, Kim TJ, Choi CH, Lee JW, Kim BG, Lee YY, Bae DS. Cancer Res Treat. 2017 Jul;49(3):635-642. doi: 10.4143/crt.2016.282. Epub 2016 Sep 27.j.ygyno.2016.08.321. Epub 2016 Aug 25.
- Timing and patterns of recurrence in epithelial ovarian cancer patients with no gross residual disease after primary debulking surgery. Paik ES, Lee YY, Shim M, Choi HJ, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS. Aust N Z J Obstet Gynaecol. 2016 Dec;56(6):639-647. doi: 10.1111/ajo.12529. Epub 2016 Sep 9.
- Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer. Paik ES, Kim TJ, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS. J Gynecol Oncol. 2016 Sep;27(5):e46. doi: 10.3802/jgo.2016.27.e46. Epub 2016 May 9.
- Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer. Paik ES, Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS. J Gynecol Oncol. 2016 May;27(3):e24. doi: 10.3802/jgo.2016.27.e24.
- Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors. Paik ES, Yoon A, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG. J Gynecol Oncol. 2015 Oct;26(4):270-6. doi: 10.3802/jgo.2015.26.4.270. Epub 2015 Jul 17.
- Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification. Paik ES, Lee YY, Lee EJ, Choi CH, Kim TJ, Lee JW, Bae DS, Kim BG. Obstet Gynecol Sci. 2015 Mar;58(2):124-34. doi: 10.5468/ogs.2015.58.2.124. Epub 2015 Mar 16.
서울특별시 종로구 새문안로 29 (03181) 강북삼성병원
대표전화 1599-8114
팩스번호 02-2001-2117
사업자번호 110-82-02349
Copyright(c) by Kangbuk Samsung hospital. all right reserved.